KPJ Healthcare Berhad (KLSE:KPJ)
Malaysia · Delayed Price · Currency is MYR 2.550
0.00 (0.00%)
At close: Sep 21, 2026
KPJ Healthcare Berhad Ratios and Metrics
Market cap in millions MYR. Fiscal year is January - December.
Millions MYR. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 11,287 | 11,766 | 10,605 | 6,285 | 4,387 | 4,803 | |
Market Cap Growth | 3.45% | 10.94% | 68.75% | 43.27% | -8.67% | 12.22% |
Enterprise Value | 14,326 | 15,142 | 13,792 | 9,367 | 7,724 | 7,780 |
Last Close Price | 2.55 | 2.66 | 2.36 | 1.37 | 0.94 | 1.01 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 28.08 | 32.15 | 29.97 | 23.86 | 26.27 | 87.67 |
Forward PE | 25.50 | 32.41 | 34.52 | 27.64 | 24.34 | 27.27 |
PS Ratio | 2.50 | 2.76 | 2.72 | 1.84 | 1.53 | 1.85 |
PB Ratio | 3.48 | 3.92 | 3.87 | 2.49 | 1.86 | 2.13 |
P/TBV Ratio | 4.07 | 4.60 | 4.53 | 2.88 | 2.17 | 2.51 |
P/FCF Ratio | 16.42 | 18.89 | 23.03 | 14.96 | 19.45 | 24.55 |
P/OCF Ratio | 12.14 | 13.17 | 12.63 | 9.56 | 9.54 | 11.65 |
PEG Ratio | 3.02 | 3.00 | 1.86 | 0.82 | 0.86 | 90.91 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 3.17 | 3.56 | 3.54 | 2.74 | 2.69 | 3.00 |
EV/EBITDA Ratio | 12.84 | 16.17 | 15.68 | 12.70 | 12.97 | 17.62 |
EV/EBIT Ratio | 18.04 | 21.51 | 20.55 | 17.35 | 19.05 | 30.41 |
EV/FCF Ratio | 20.84 | 24.31 | 29.96 | 22.30 | 34.24 | 39.76 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 1.22 | 1.32 | 1.34 | 1.51 | 1.59 | 1.40 |
Debt / EBITDA Ratio | 3.72 | 3.91 | 3.86 | 4.71 | 5.66 | 6.30 |
Debt / FCF Ratio | 5.74 | 6.37 | 7.98 | 9.10 | 16.62 | 16.09 |
Net Debt / Equity Ratio | 0.86 | 0.97 | 1.10 | 1.18 | 1.37 | 1.24 |
Net Debt / EBITDA Ratio | 2.84 | 3.12 | 3.43 | 4.05 | 5.43 | 6.30 |
Net Debt / FCF Ratio | 4.03 | 4.69 | 6.54 | 7.12 | 14.33 | 14.21 |
Asset Turnover | 0.57 | 0.55 | 0.53 | 0.48 | 0.44 | 0.42 |
Inventory Turnover | 24.05 | 26.23 | 28.11 | 28.61 | 28.36 | 31.45 |
Quick Ratio | 1.52 | 1.42 | 1.15 | 1.10 | 0.73 | 0.57 |
Current Ratio | 1.60 | 1.52 | 1.24 | 1.19 | 0.88 | 0.77 |
Return on Equity (ROE) | 14.49% | 13.98% | 13.90% | 12.39% | 8.77% | 3.25% |
Return on Assets (ROA) | 5.84% | 5.70% | 5.73% | 4.74% | 3.85% | 2.59% |
Return on Invested Capital (ROIC) | 8.76% | 8.50% | 8.11% | 7.72% | 5.55% | 3.04% |
Return on Capital Employed (ROCE) | 10.80% | 10.50% | 11.00% | 9.20% | 7.60% | 5.60% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 18, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 3.55% | 3.11% | 3.34% | 4.19% | 3.81% | 1.14% |
FCF Yield | 6.09% | 5.29% | 4.34% | 6.68% | 5.14% | 4.07% |
Dividend Yield | 1.62% | 1.55% | 1.76% | 2.26% | 2.14% | 0.55% |
Payout Ratio | 48.50% | 50.45% | 51.19% | 55.51% | 52.02% | 43.31% |
Buyback Yield / Dilution | -0.94% | -0.30% | -0.07% | 1.86% | -0.64% | 0.99% |
Total Shareholder Return | 0.68% | 1.25% | 1.68% | 4.12% | 1.50% | 1.53% |